Prevalence and correlates of Trichomonas vaginalis among incarcerated persons assessed using a highly sensitive molecular assay

Sexually Transmitted Diseases

Volumn 37, Issue 3, 2010, Pages 165-168

  Freeman, Alexandra H ^a   Katz, Kenneth A ^a,b   Pandori, Mark W ^c   Rauch, Leah M ^c   Kohn, Robert P ^a   Liska, Sally ^c   Bernstein, Kyle T ^a   Klausner, Jeffrey D ^a  

^a SAN FRANCISCO DEPARTMENT OF PUBLIC HEALTH   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c SAN FRANCISCO DEPARTMENT OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CLINICAL ASSESSMENT; DIAGNOSTIC ACCURACY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MOLECULAR BIOLOGY; NONHUMAN; PREVALENCE; PRISON; SCREENING; TRICHOMONAS VAGINALIS; TRICHOMONIASIS; UNITED STATES; URINALYSIS;

ADOLESCENT; ADULT; AGE FACTORS; FEMALE; HUMANS; MALE; MIDDLE AGED; NUCLEIC ACID AMPLIFICATION TECHNIQUES; PREVALENCE; PRISONERS; SAN FRANCISCO; SENSITIVITY AND SPECIFICITY; SPECIMEN HANDLING; TRICHOMONAS INFECTIONS; TRICHOMONAS VAGINALIS; TRICHOMONAS VAGINITIS; YOUNG ADULT;

EID: 77649129783     PISSN: 01485717     EISSN: None     Source Type: Journal    
DOI: 10.1097/OLQ.0b013e3181bcd3fc     Document Type: Article

References (41)

1. Cates W Jr. Estimates of the incidence and prevalence of sexually transmitted diseases in the United States. American Social Health Association Panel. Sex Transm Dis 1999; 26:S2-S7.
2. Weinstock H, Berman S, Cates W. Sexually transmitted diseases among American youth: Incidence and prevalence estimates, 2000. Perspect Sex Reprod Health 2004; 36:6-10.
3. Moodley P, Wilkinson D, Connolly C, et al. Trichomonas vagi-nalis is associated with pelvic inflammatory disease in women infected with human immunodeficiency virus. Clin Infect Dis 2002; 34:519-522.
4. Zhang Z, Begg CB. Is Trichomonas vaginalis a cause of cervical neoplasia? Results from a combined analysis of 24 studies. Int J Epidemiol 1994; 23:682-690.
5. Swygard H, Sena AC, Hobbs MM, et al. Trichomoniasis: Clinical manifestations, diagnosis and management. Sex Transm Infect 2004; 80:91-95.
6. Cotch MF, Ii JGP, Nugent RP, et al. Trichomonas vaginalis associated with low birth weight and preterm delivery. Sex Transm Dis 1997; 24:353.
7. Sutton MY, Sternberg M, Nsuami M, et al. Trichomoniasis in pregnant human immunodeficiency virus-infected and human immunodeficiency virus-uninfected Congolese women: Prevalence, risk factors, and association with low birth weight. Am J Obstet Gynecol 1999; 181:656.
8. Minkoff H, Grunebaum AN, Schwarz RH, et al. Risk factors for prematurity and premature rupture of membranes: A prospective study of the vaginal flora in pregnancy. Am J Obstet Gynecol 1984; 150:965-972.
9. Krieger JN, Jenny C, Verdon M, et al. Clinical manifestations of trichomoniasis in men. Ann Intern Med 1993; 118:844-849.
10. Krieger JN, Verdon M, Siegel N, et al. Natural history of uro-genital trichomoniasis in men. J Urol 1993; 149:1455-1458.
11. Laga M, Manoka A, Kivuvu M, et al. Non-ulcerative sexually transmitted diseases as risk factors for HIV-1 transmission in women: Results from a cohort study. AIDS 1993; 7:95.
12. Wawer MJ, Sewankambo NK, Serwadda D, et al. Control of sexually transmitted diseases for AIDS prevention in Uganda: A randomised community trial. Rakai Project Study Group. Lancet 1999; 353:525-535.
13. Van Der Pol B, Kwok C, Pierre-Louis B, et al. Trichomonas vaginalis infection and human immunodeficiency virus acquisition in African women. J Infect Dis 2008; 197:548-554.
14. Van Der Pol B. Trichomonas vaginalis infection: The most prevalent nonviral sexually transmitted infection receives the least public health attention. Clin Infect Dis 2007; 44:13-22.
15. Borchardt KA, al-Haraci S, Maida N. Prevalence of Trichomonas vaginalis in a male sexually transmitted disease clinic population by interview, wet mount microscopy, and the InPouch TV test. Genitourin Med 1995; 71:405-406.
16. Joyner JL, Douglas JM Jr, Ragsdale S, et al. Comparative prevalence of infection with Trichomonas vaginalis among men attending a sexually transmitted diseases clinic. Sex Transm Dis 2000; 27:236-240.
17. Krieger JN, Verdon M, Siegel N, et al. Risk assessment and laboratory diagnosis of trichomoniasis in men. J Infect Dis 1992; 166:1362-1366.
18. Bunnell RE, Dahlberg L, Rolfs R, et al. High prevalence and incidence of sexually transmitted diseases in urban adolescent females despite moderate risk behaviors. J Infect Dis 1999; 180: 1624-1631.
19. Spence MR, Hollander DH, Smith J, et al. The clinical and laboratory diagnosis of Trichomonas vaginalis infection. Sex Transm Dis 1980; 7:168-171.
20. Wendel KA, Erbelding EJ, Gaydos CA, et al. Trichomonas vaginalis polymerase chain reaction compared with standard diagnostic and therapeutic protocols for detection and treatment of vaginal tricho-moniasis. Clin Infect Dis 2002; 35:576-580.
21. Shuter J, Bell D, Graham D, et al. Rates of and risk factors for trichomoniasis among pregnant inmates in New York city. Sex Transm Dis 1998; 25:303.
22. Klausner JD, Baer JT, Contento KM, et al. Investigation of a suspected outbreak of vaginal trichomoniasis among female inmates. Sex Transm Dis 1999; 26:335-338.
23. Miller M, Liao Y, Gomez AM, et al. Factors associated with the prevalence and incidence of Trichomonas vaginalis infection among African am women in New York city who use drugs. J Infect Dis 2008; 197:503.
24. Fouts AC, Kraus SJ. Trichomonas vaginalis: Reevaluation of its clinical presentation and laboratory diagnosis. J Infect Dis 1980; 141:137-143.
25. McCann JS. Comparison of direct microscopy and culture in the diagnosis of trichomoniasis. Br J Vener Dis 1974; 50:450.
26. Caliendo AM, Jordan JA, Green AM, et al. Real-time PCR improves detection of Trichomonas vaginalis infection compared with culture using self-collected vaginal swabs. Infect Dis Obstet Gynecol 2005; 13:145.
27. van der Schee C, van Belkum A, Zwijgers L, et al. Improved diagnosis of Trichomonas vaginalis infection by PCR using vaginal swabs and urine specimens compared to diagnosis by wet mount microscopy, culture, and fluorescent staining. Am Soc Microbiol 1999: 4127-4130.
28. Huppert JS, Mortensen JE, Reed JL, et al. Rapid antigen testing compares favorably with transcription-mediated amplification assay for the detection of Trichomonas vaginalis in young women. Clin Infect Dis 2007; 45:194.
29. Hardick A, Hardick J, Wood BJ, et al. Comparison between the Gen-Probe transcription-mediated amplification Trichomonas vaginalis research assay and real-time PCR for Trichomonas vaginalis detection using a Roche LightCycler instrument with female self-obtained vaginal swab samples and male urine samples. J Clin Microbiol 2006; 44:4197-4199.
30. Dicker LW, Mosure DJ, Steece R, et al. Testing for sexually transmitted diseases in US Public Health laboratories in 2004. Sex Transm Dis 2007; 34:41.
31. Mertz KJ, Voigt RA, Hutchins K, et al. Findings from STD screening of adolescents and adults entering corrections facilities: Implications for STD control strategies. Sex Transm Dis 2002; 29:834-839.
32. High prevalence of chlamydial and gonococcal infection in women entering jails and juvenile detention centers-Chicago, Birmingham, and San Francisco 1998. MMWR Morb Mortal Wkly Rep 1999; 48: 793-796.
33. Beltrami JF, Cohen DA, Hamrick JT, et al. Rapid screening and treatment for sexually transmitted diseases in arrestees: a feasible control measure. Am J Public Health 1997; 87:1423-1426.
34. Bick JA. Infection control in jails and prisons. Clin Infect Dis 2007; 45:1047-1055.
35. Hammett TM, Drachman-Jones A. HIV/AIDS, sexually transmitted diseases, and incarceration among women: national and southern perspectives. Sex Transm Dis 2006; 33:S17-S22.
36. Lossick JG. Epidemiology of Urogenital Trichomoniasis. Trichomonads Parasitic in Humans. New York, NY: Springer-Verlag, 1989: 311-323.
37. Miller WC, Swygard H, Hobbs MM, et al. The prevalence of trichomoniasis in young adults in the United States. Sex Transm Dis 2005; 32:593-598.
38. Schwebke JR, Burgess D. Trichomoniasis. Clin Microbiol Rev 2004; 17:794-803.
39. Workowski KA, Berman SM. Sexually transmitted diseases treatment guidelines, 2006. MMWR Recomm Rep 2006; 55:1-94.
40. Heine P, McGregor JA. Trichomonas vaginalis: A reemerging pathogen: Vaginitis in 1993. Clin Obstet Gynecol 1993; 36:137-144.
41. Reynolds M, Wilson J. Is Trichomonas vaginalis still a marker for other sexually transmitted infections in women? Int J STD AIDS 1996; 7:131.